Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESA LABORATORIES INC /CO/ Director's Dealing 2023

Mar 27, 2023

33153_dirs_2023-03-27_aad8ecf3-cc1b-4554-81a3-1c0460be7aad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2023-03-22

Reporting Person: Sakys John (CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-22 Common Stock M 2500 $122.66 Acquired 12196 Direct
2023-03-22 Common Stock S 2500 $171.62 Disposed 9696 Direct
2023-03-24 Common Stock M 1000 $122.66 Acquired 10696 Direct
2023-03-24 Common Stock S 1000 $167.01 Disposed 9696 Direct
2023-03-24 Common Stock M 1128 $51.85 Acquired 10824 Direct
2023-03-24 Common Stock S 1128 $167.01 Disposed 9696 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-22 Non Qualified Stock Option $122.66 X 2500 Disposed 2023-04-03 Common Stock (2500) Direct
2023-03-24 Non Qualified Stock Option $122.66 X 1000 Disposed 2023-04-03 Common Stock (1000) Direct
2023-03-24 Non Qualified Stock Option $51.85 X 1128 Disposed 2023-04-01 Common Stock (1128) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100 Indirect

Footnotes

F1: 1/5 exercisable on each anniversary date of the 04/03/17 grant date

F2: 1/4 exercisable on each anniversary date of the 04/01/2013 grant date

F3: Sale reported on the Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 14, 2022

F4: Consists of 100 shares held by children of which Mr. Sakys is custodian